A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)

Merck Sharp & Dohme (MSD)

Status and phase: Completed; Phase 3

Conditions: Postoperative Pain

Treatments: Drug: Comparator: diclofenac sodium, placebo; Drug: MK0966, rofecoxib

Study type: Interventional

Funder types: Industry

Identifiers

NCT00092378

2004_072

0966-234

Details and patient eligibility

About

This purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following bunionectomy surgery.

Full description

The duration of treatment is 5 days for rofecoxib and 1 day for diclofenac sodium.

Enrollment: 251 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Bunion removal

Exclusion criteria

• Any known allergies to the study design

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind